CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Pulsed Field Ablation of epicardial Ganglionated Plexi.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05426759
NCT05426759N/ACompleted
CompareCT.gov

Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation

Atrian Medical Ltd.·interventional·Posted Jun 22, 2022·Updated Jul 3, 2024

In Brief

A clinical study evaluating Pulsed Field Ablation of epicardial Ganglionated Plexi. for Atrial Fibrillation. Completed, enrolled 12 participants across 1 site.

Detailed Summary

A prospective single-arm study of ganglionated plexi ablation in cardiothoracic surgery patients with a history of atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesGeorgia
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 22, 2022
Enrollment StartJun 1, 2022
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.0 years ago

Interventions

Pulsed Field Ablation of epicardial Ganglionated Plexi.device

Using Pulsed Field Ablation (PFA), delivered via an epicardial catheter, to selectively ablate the ganglionated plexi (GP) on the epicardial surface of the heart.